Potentially inappropriate medication in elderly hospitalized patients.

Drugs & Aging
Andrea CorsonelloFabrizia Lattanzio

Abstract

Balanced and safe prescribing is difficult to achieve in frail older adults with multiple comorbid diseases. This issue is of particular concern, especially in elderly hospitalized patients because hospitalization exposes such individuals to an increased risk of adverse drug reactions (ADRs). The avoidance of medications that are considered to be inappropriate is among the interventions for treatment options in elderly patients. A potentially inappropriate medication (PIM) is a drug in which the risk of an adverse event outweighs its clinical benefit, particularly when there is a safer or more effective alternative therapy for the same condition. Explicit criteria have been developed to identify PIMs and among these, Beers' criteria are the most frequently applied in the literature. However, evidence suggests that such criteria cannot easily be applied to elderly hospitalized people in European countries; approximately 20% of drugs listed in Beers' criteria are rarely prescribed or are not available in Europe, and Beers' listed PIMs are not associated with inhospital mortality, length of hospital stay and/or ADRs in Italian studies. On the contrary, ADRs can contribute to accelerated functional decline in elderly hospitalized p...Continue Reading

References

Dec 1, 1994·Journal of the American Geriatrics Society·K SchmaderJ R Feussner
Jul 27, 1994·JAMA : the Journal of the American Medical Association·S M WillcoxS Woolhandler
Jan 22, 1997·JAMA : the Journal of the American Medical Association·D C ClassenJ P Burke
Mar 1, 1997·American Journal of Public Health·D L SporeJ Hiris
Aug 1, 1997·Journal of the American Geriatrics Society·J T HanlonI K Lewis
Oct 24, 1997·Archives of Internal Medicine·J L BootmanE Cox
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Aug 25, 1999·Drugs & Aging·A R Moore, S T O'Keeffe
Sep 10, 1999·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·L CarosellaP Carbonin
Jan 7, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A CrucittiA Mugelli
Aug 5, 2000·The Annals of Pharmacotherapy·R R Aparasu, J R Mort
Feb 24, 2001·Journal of the American Geriatrics Society·J T HanlonM Weinberger
May 25, 2002·Journal of the American Geriatrics Society·Joseph T HanlonJudith Garrard
Aug 20, 2002·European Journal of Clinical Pharmacology·Graziano OnderRoberto Bernabei
Dec 11, 2002·Journal of the American Geriatrics Society·Graziano OnderGiovanni Gambassi
Feb 7, 2003·Quality & Safety in Health Care·E M Schimmel
May 8, 2003·European Journal of Clinical Pharmacology·Graziano OnderUNKNOWN Investigators of the GIFA Study
Jan 8, 2004·Mayo Clinic Proceedings·Darryl S ChutkaRobert W Hoel
Mar 6, 2004·Stroke; a Journal of Cerebral Circulation·Stefano VolpatoUNKNOWN Gruppo Italiano di Farmacoepidemiologia nell'Anziano (GIFA)
Dec 31, 2004·The New England Journal of Medicine·Mary E TinettiJoseph V Agostini
Mar 17, 2005·JAMA : the Journal of the American Medical Association·Daniela FialováUNKNOWN AdHOC Project Research Group
Apr 13, 2005·Archives of Internal Medicine·Andrea CorsonelloUNKNOWN Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA) Investigators
May 21, 2005·Drugs & Aging·Louis MerleJean-Pierre Charmes
May 25, 2005·European Journal of Clinical Pharmacology·Graziano OnderRoberto Bernabei
Aug 11, 2005·JAMA : the Journal of the American Medical Association·Cynthia M BoydAlbert W Wu
Sep 27, 2005·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Andrea CorsonelloUNKNOWN Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA)
Mar 29, 2006·Archives of Internal Medicine·Holly M HolmesGreg A Sachs
Sep 15, 2006·Journal of the American Geriatrics Society·Andrea CorsonelloRaffaele Antonelli Incalzi
Dec 15, 2006·British Journal of Clinical Pharmacology·Marie-Laure LarocheLouis Merle
Mar 27, 2007·Journal of Clinical Pharmacy and Therapeutics·P GallagherD O'Mahony
May 11, 2007·International Journal of Cardiology·Antonino TuttolomondoUNKNOWN Gruppo Italiano di Farmacoepidemiologia dell'Anziano (GIFA) researchers
Jun 8, 2007·European Journal of Clinical Pharmacology·Marie-Laure LarocheLouis Merle
Jun 15, 2007·European Journal of Clinical Pharmacology·Francesco LandiGraziano Onder
Jan 9, 2008·European Journal of Clinical Pharmacology·Shaojun ShiUlrich Klotz
Jan 26, 2008·International Journal of Clinical Pharmacology and Therapeutics·P GallagherD O'Mahony
Mar 20, 2008·Age and Ageing·Denis O'Mahony, Paul Francis Gallagher
Mar 25, 2008·Therapeutics and Clinical Risk Management·Andrea CorsonelloRaffaele Antonelli Incalzi

❮ Previous
Next ❯

Citations

Oct 18, 2013·Intensive Care Medicine·Patrick BistonDaniel De Backer
Aug 14, 2012·Drug, Healthcare and Patient Safety·Anita ConfortiRoberto Leone
Apr 20, 2014·International Journal of Clinical Pharmacy·Klejda HudhraAurora Bueno-Cavanillas
Jan 1, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Fabio SalviAntonio Cherubini
Dec 20, 2011·Revista de calidad asistencial : organo de la Sociedad Española de Calidad Asistencial·S E Garcia-RamosF Ramos-Diaz
Jul 8, 2011·Revista clínica española·R Fernández-RegueiroJ Morís-De-La-Tassa
Jan 22, 2015·Age and Ageing·Lucas MorinRégis Aubry
Jan 11, 2018·Journal of the American Geriatrics Society·Ula HwangUNKNOWN GEDI WISE Investigators
Jun 20, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Chanel F WhittakerJeffrey C Fink
Jul 18, 2020·The International Journal of Pharmacy Practice·Mariam ZahweAmal Al-Hajje
Mar 16, 2017·Frontiers in Medicine·Silvia MartínCesar Aldecoa
Feb 14, 2020·International Journal for Equity in Health·Sudeh Cheraghi-SohiCaroline Sanders
May 4, 2017·International Journal of Clinical Pharmacy·Tácita Pires de FigueiredoAdriano Max Moreira Reis
May 8, 2021·Journal of the American Geriatrics Society·Maria UkhanovaAna R Quiñones
Aug 12, 2021·International Journal of Clinical Practice·Asma Ahmed AbdelwahedKhuloud Jamal Bin Rafeea
Sep 29, 2021·Journal of the American Pharmacists Association : JAPhA·Osama Mohamed IbrahimRana M Ibrahim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved